Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3638344 Target Snapshot

Genome polyprotein · SINGLE PROTEIN · Hepatitis C virus genotype 1a (isolate H) (HCV)

1,154Compounds
12Assays
0Approved Drugs
1,207.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Genome polyprotein shows clinical signal disease relevance led by hepatitis C virus infection. 1 linked drug keeps the current disease frame grounded. Protein identity stays anchored to UniProt P27958. Start with hepatitis C virus infection, then reuse UniProt P27958 as the stable protein anchor across project notes and exports.

Review focus
Review-ready target frame

Start with hepatitis C virus infection, then reuse UniProt P27958 as the stable protein anchor across project notes and exports.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14 1 linked drug
Open source guide
Disease program
hepatitis C virus infection

Genome polyprotein shows clinical signal disease relevance led by hepatitis C virus infection. 1 linked drug remains visible in the same block.

Start review with hepatitis C virus infection because it currently carries clinical signal support. Linked drugs include MBL-HCV-1. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

Disease source · ChEMBL drug mechanism + indication proxy
Clinical signal Open Targets-ready proxy 1 linked drug
Open disease block
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Genome polyprotein as ChEMBL target CHEMBL3638344, mapped to UniProt P27958. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Genome polyprotein
SINGLE PROTEIN · Hepatitis C virus genotype 1a (isolate H) (HCV)
As of 2026-09-14
ChEMBL target ID
CHEMBL3638344
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P27958
Genome polyprotein
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Genome polyprotein is the right protein anchor across sources, using UniProt P27958 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need to confirm why hepatitis C virus infection is currently framed as clinical signal support. It currently carries 1 linked drug in the same disease frame.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGenome polyprotein
UniProt AccessionP27958
Component TypeProtein
Sequence Length3011 aa

Genome polyprotein

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Genome polyprotein, mapped to UniProt P27958. Sequence length is 3011 aa.

Mapped IDP27958
Review nameGenome polyprotein
OrganismHepatitis C virus genotype 1a (isolate H) (HCV)
Disease Relevance

Disease Relevance & Evidence Level

Open Targets-ready disease context using the current target-indication evidence contract.

Clinical signal Open Targets-ready proxy

Genome polyprotein shows clinical signal disease relevance led by hepatitis C virus infection.

Clinical signal Phase II
hepatitis C virus infection
1 linked drug · 1 direct · 1 efficacy
Linked drugMBL-HCV-1
Source · ChEMBL drug mechanism + indication proxy
Review Cue

How to read disease relevance

Start review with hepatitis C virus infection because it currently carries clinical signal support. Linked drugs include MBL-HCV-1. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

Lead diseasehepatitis C virus infection
Strongest levelClinical signal
Block modeOpen Targets-ready proxy
Clinical Profile

Clinical Phase Distribution

1
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50897.0
KI6.0
EC50304.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3645737 9.3 IC50 0.5 Preclinical
CHEMBL3645734 9.22 IC50 0.6 Preclinical
CHEMBL3645741 9.22 IC50 0.6 Preclinical
CHEMBL3953901 9.22 IC50 0.6 Preclinical
CHEMBL3971537 9.22 IC50 0.6 Preclinical
CHEMBL3939023 9.15 IC50 0.7 Preclinical
CHEMBL3645729 9.1 IC50 0.8 Preclinical
CHEMBL3645615 9.05 IC50 0.9 Preclinical
CHEMBL3645622 9.05 IC50 0.9 Preclinical
CHEMBL3909191 9.05 IC50 0.9 Preclinical
Distribution

pChEMBL Value Distribution

34
5.0
69
5.5
137
6.0
145
6.5
206
7.0
152
7.5
215
8.0
152
8.5
23
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

12
Total Assays
1,135
Tested Compounds
1
Assay Types
Binding — 12 assays, 1,135 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 7 768 6.9
assay format 4 350 8.1
cell-free format 1 17 8.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine